Albemarle (ALB) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $3.75
- EPS estimate
- $3.20
- EPS surprise
- +17.09%
- Revenue surprise
- +8.49%
- Revenue
- $1.7B
- Revenue estimate
- $1.6B
- Reported
- Aug 5, 2026
Albemarle reported Q2 2026 results on August 5, 2026. Earnings per share came in at $3.75, ahead of the $3.20 estimate by 17.09%. Revenue was $1.7 billion, above the $1.6 billion consensus by about 8.5%. Compared with Q2 2025, EPS rose from just $0.11, and revenue rose about 31% from $1.3 billion. Q1 2026 had beaten its estimate by 147.03%.
Annual EPS was $21.95 in 2022 and $22.24 in 2023, with a peak of $10.32 per share in Q1 2023. Albemarle then posted a loss of $2.34 per share for 2024 and a loss of $0.79 for 2025, with losses in five of those eight quarters. The deepest was $1.55 in Q3 2024. Quarterly revenue fell from $2.6 billion in early 2023 to $1.1–1.4 billion in 2024 and 2025. The first half of 2026 adds up to $6.70 per share, against a combined loss of $0.07 a year earlier. Over the last 20 quarters, Albemarle beat the EPS estimate 15 times.
Albemarle reported Q3 between November 1 and November 6 in each of the past five years. That points to early November 2026 for the next report, which will show whether the return to profit seen in 2026 holds.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | $3.20 | $3.75 | +17.09% | $1.7B | SEC |
| Q1 2026 | May 6, 2026 | $1.19 | $2.95 | +147.03% | $1.4B | SEC |
| Q4 2025 | Feb 11, 2026 | −$0.42 | −$0.53 | −26.85% | $1.4B | SEC |
| Q3 2025 | Nov 5, 2025 | −$0.86 | −$0.19 | +77.95% | $1.3B | SEC |
| Q2 2025 | Jul 30, 2025 | −$0.84 | $0.11 | +113.14% | $1.3B | SEC |
| Q1 2025 | Apr 30, 2025 | −$0.66 | −$0.18 | +72.75% | $1.1B | SEC |
| Q4 2024 | Feb 12, 2025 | −$0.69 | −$1.09 | −57.99% | $1.2B | SEC |
| Q3 2024 | Nov 6, 2024 | −$0.44 | −$1.55 | −253.24% | $1.4B | SEC |
| Q2 2024 | Jul 31, 2024 | $0.43 | $0.04 | −90.63% | $1.4B | SEC |
| Q1 2024 | May 1, 2024 | $0.25 | $0.26 | +2.89% | $1.4B | SEC |
| Q4 2023 | Feb 14, 2024 | $0.98 | $1.85 | +88.08% | $2.4B | SEC |
| Q3 2023 | Nov 1, 2023 | $3.75 | $2.74 | −26.99% | $2.3B | SEC |
| Q2 2023 | Aug 2, 2023 | $4.48 | $7.33 | +63.59% | $2.4B | SEC |
| Q1 2023 | May 3, 2023 | $7.27 | $10.32 | +41.99% | $2.6B | SEC |
| Q4 2022 | Feb 15, 2023 | $8.26 | $8.62 | +4.35% | $2.6B | SEC |
| Q3 2022 | Nov 2, 2022 | $6.97 | $7.50 | +7.59% | $2.1B | SEC |
| Q2 2022 | Aug 3, 2022 | $3.11 | $3.45 | +10.95% | $1.5B | SEC |
| Q1 2022 | May 4, 2022 | $1.64 | $2.38 | +45.34% | $1.1B | SEC |
| Q4 2021 | Feb 16, 2022 | $1.00 | $1.01 | +1.35% | $894.2M | SEC |
| Q3 2021 | Nov 3, 2021 | $0.77 | $1.05 | +36.88% | $830.6M | SEC |
Quarterly revenue
Frequently asked questions
When did Albemarle (ALB) last report earnings?
Albemarle last reported on Aug 5, 2026, covering fiscal Q2 2026.
Did ALB beat earnings estimates?
Yes. Albemarle reported EPS of $3.75 for Q2 2026 against a $3.20 estimate — a 17.09% beat.
How much revenue did ALB report last quarter?
Albemarle reported $1.7B in revenue for Q2 2026, against a consensus estimate of $1.6B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.